Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Bird flu pandemic would require multi-drug approach

Scientists have uncovered a change in the H5N1 bird flu virus which makes it resistant to the anti-viral drug Tamiflu. The mutation in the N1 component was found in human cases of the disease and suggests that a single drug approach is likely to be ineffective in case of a bird flu pandemic in humans. The findings by a team at the Medical Research Council's National Institute for Medical Research are published in Nature.

15 May 2008

China struggles to cope with killer virus amid earthquake devastation

The death toll in China from hand-foot-mouth disease has now risen to 42 with another 24,934 children sickened by the deadly virus; all the fatalities have been children.

15 May 2008

Getting sick in Victoria could be a worry

In what will be great concern to Australians living in Victoria, a newly released report has found that Victoria's hospitals have failed to meet key performance indicators.

15 May 2008

Another outbreak of bird flu in Seoul - all poultry in the city culled

A second outbreak of bird flu in Seoul, the capital of South Korea in less than a week has prompted the culling of all domestic fowl in the city.

13 May 2008

New plan says no vaccination no school

New proposals by Britain's Labour government will see children banned from starting primary school unless they have been vaccinated.

12 May 2008

Japanese authorities fear bird flu spread in wild birds

The discovery of another swan killed by bird flu in Japan has concerned health authorities.

11 May 2008

CDC report finds increase in reports of respiratory illness in children after hurricane Katrina; New Orleans Mayor pushes for city residents to leave trailers

The number of children in the Gulf Coast region after Hurricane Katrina who complained of symptoms of bronchitis, pneumonia and other lower respiratory illnesses rose in the years after the storm, according to a 49-page CDC report released on Thursday, the Washington Post reports.

11 May 2008

microRNAs provide more clues to genetics of schizophrenia

Researchers at Columbia University Medical Center have illuminated a window into how abnormalities in microRNAs, a family of molecules that regulate expression of numerous genes, may contribute to the behavioral and neuronal deficits associated with schizophrenia and possibly other brain disorders.

11 May 2008

Researchers launch lung cancer screening trial

Scientists are testing a new way of detecting lung cancer at an early stage in people at greatest risk of developing the disease.

9 May 2008

FDA approves Strattera for ADHD in children and adolescents

Eli Lilly and Company announced today that the United States Food and Drug Administration (FDA) has approved Strattera (atomoxetine HCI) for maintenance treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. Strattera, a selective norepinephrine reuptake inhibitor, is the first FDA-approved non-stimulant to treat ADHD in children, adolescents and adults.

8 May 2008

Bird flu pandemic risk just as real and probably growing

Experts are warning that the risk of a human bird flu pandemic remains just as real and is in fact probably growing.

8 May 2008

Experts review influenza pandemic preparedness guidance

With the onging threat of a global influenza pandemic demanding continued vigilance, 120 influenza and planning experts from WHO Member States, research institutions and UN agencies around the globe are meeting in Geneva this week to review the current WHO pandemic preparedness guidance. Key scientific and situational developments make the review particularly important. WHO will release the revised guidance later this year.

7 May 2008

GenVec announces grant for respiratory syncytial virus vaccine program

GenVec, Inc. announced today that it has received an Advanced Technology Phase I Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases, of the National Institutes of Health, to support the Company's efforts to develop vaccines for the prevention of respiratory syncytial virus (RSV).

7 May 2008

Bird flu pandemic risk just as real and probably growing

Experts are warning that the risk of a human bird flu pandemic remains just as real and is in fact probably growing.

7 May 2008

Relief in sight for arthritis triggered by viral infections such as Ross River fever

Australian scientists believe they may have discovered the possibility of relief for those suffering with the debilitating arthritis triggered by viral infections such as Ross River fever.

6 May 2008

Computer keyboard five times filthier than the toilet seat!

According to scientists in Britain your computer keyboard could contain a virus which threatens more than just what is on the screen - they say it poses a considerable health risk which equates to those presented by a toilet seat.

6 May 2008

MRSA spreading say American Society of Registered Nurses

Today the American Society of Registered Nurses announced that cases of MRSA also known as Methicillin - Resistant Staphylococcus aureus often called "Staph" are on the rise.

5 May 2008

New weapon against respiratory syncytial virus

University of Texas Medical Branch at Galveston researchers have achieved promising results with a potential new weapon against respiratory syncytial virus, the most common cause of infant hospitalization in the United States.

5 May 2008

Strange barriers to physical activity may exist at child-care centers

At a time when over half of US children (aged 3-6) are in child care centers, and growing concern over childhood obesity has led physicians to focus on whether children are getting enough physical activity, a new study of outdoor physical activity at child care centers, conducted by researchers at Cincinnati Children's Hospital Medical Center, has identified some surprising reasons why the kids may be staying inside.

5 May 2008

Anti-HIV NanoViricide drug candidate shows promise in animal trials

NanoViricides, Inc said that its anti-HIV drug candidates demonstrated significant therapeutic efficacy in the recently completed preliminary animal studies.

5 May 2008